Bio-Rad Laboratories, Inc.
BIO · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $2.58B | $2.57B | +0.7% |
| Operating income | $47.2M | $269M | −82.5% |
| Net income | $760M | −$1.84B |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $656M | $653M | +0.5% |
| Operating income | −$49.7M | $65.3M | |
| Net income | $459M | −$342M |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Bio-Rad's revenue in FY2025?
- $2.58B in FY2025 (Fiscal year ended Dec 31, 2025), +0.7% vs $2.57B a year earlier, per its 10-K filed Feb 2026.
- Was Bio-Rad profitable in FY2025?
- Yes: net income was $760M and operating income $47.2M in FY2025.
- What was Bio-Rad's revenue in Q3 2026?
- $656M (+0.5% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.